Equity Research, Broker Reports, and media content on Redx Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Redx Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Redx Pharma Plc

Company Profile

  • Personnel
  • James Mead, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Redx Pharma Plc. We currently have 89 research reports from 6 professional analysts.

  • Open: 65.0p
  • Range Today: 62.5/67.2p
  • 52 Week: 0.00/0.00p
  • Daily Volume: 1.2k
  • Daily Liquidity: (0.00%)
  • # Shares: 195.2m
  • Market Cap: £0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
05May21 07:00 RNS Appointment of Peter Collum as CFO
30Apr21 09:00 RNS Confirmation of post offer intention statements
28Apr21 07:00 RNS Dosing of first patients with RXC004 and Anti-PD1
29Mar21 09:00 RNS Redx to present at AACR
15Mar21 07:00 RNS Appointment of Joint Broker
02Mar21 12:38 RNS Result of AGM and Directorate change
01Mar21 09:57 RNS New Grant of Options
  • Frequency of research reports


  • Research reports on

    Redx Pharma Plc

  • Providers covering

    Redx Pharma Plc